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The Global Burden of Diseases, Injuries, and Risk Factors Study for 2019 (GBD 2019) provides a rules-5 
based synthesis of the available evidence on levels and trends in health outcomes, a diverse set of risk 6 
factors, and health system responses, covering 204 countries and territories as well as first 7 
administrative level disaggregations for 22 countries, from 1990 to 2019. Because GBD is highly 8 
standardised and comprehensive, spanning both fatal and non-fatal outcomes, and uses a mutually 9 
exclusive and collectively exhaustive hierarchical disease and injury cause list, it provides a powerful 10 
basis for both detailed and broad insights on global health trends and emerging challenges. GBD 2019 11 
incorporates data from 112 493 sources. GBD 2019 provides more than 3.5 billion estimates of health 12 
outcome and health system measures of interest for global, national, and sub-national policy dialogue, 13 
all of which are publicly available at www.healthdata.org/gbd-compare. All GBD estimates adhere to the 14 
Guidelines on Accurate and Transparent Health Estimate Reporting (GATHER).1 From this massive 15 
amount of information, we distill five key insights that are important for health and development 16 
strategies. These insights are subject to the many limitations outlined in each of the component GBD 17 
capstone papers.2–6  18 
1. Double down on catch-up development 19 
In GBD, we track a population’s social and economic development status for each location-year based 20 
on the Socio-demogrpahic Index (SDI), which combines information on GDP per capita, average years of 21 
schooling over age 25, and the total fertility rate under age 25 (as a widely available inverse proxy for 22 
the status of girls and women in society).7 7 SDI ranges from 0 to 100. Since 1950, global SDI has 23 
increased monotonically from 35 to 65. The average pace of progress accelerated from 1950 to 1980 24 
and has since stayed around 0.5 units per year. For the 15% of countries with the fastest rate of 25 
increase, SDI improved, on average, by 0.9 units per year since 1980, but it has improved by less than 26 
one third this rate—0.3 units per year—for the bottom 15% of countries. Social and economic 27 
development can take centuries; given what we have seen from 1950 to 2019, the average country 28 
would take about 184 years to progress from an SDI of 0 to an SDI of 100; countries in the bottom 15% 29 
will take 357 and those in the top 15% 110 years. From 1950 to 2000, the pace of improvement in SDI 30 
was positively correlated with the level of SDI: higher SDI countries were developing faster. Since 2000, 31 
the correlation has become progressively more negative and is currently around -0.5; in other words, 32 
since the Millennium Declaration,8 countries with lower SDI levels have had larger annual increases, 33 
Inequality in SDI between countries measured using the standard deviation of SDI has been decreasing 34 
since 2000; we are witnessing catch-up development. 35 
Social and economic development, measured using SDI, is very highly correlated with health outcomes.2 36 
Figure 1 shows the increase in healthy life expectancy (HALE) from 2000 to 2019, divided by what could 37 
be expected on the basis of SDI change alone and what is unexplained by SDI, namely some combination 38 
of new technologies, prioritisation of societal resources for health, and the emergence of public health 39 
challenges such as the HIV epidemic or alcohol consumption in eastern Europe and central Asia. Given 40 
the overwhelming impact of SDI on recent health progress, doubling down on policies and strategies 41 
that stimulate economic growth, expand access to primary and secondary schooling, and improve the 42 
status of women should be our collective priority. The catch-up social and economic development 43 
clearly evident since the Millennium Declaration provides some optimism that maintaining focus on the 44 
worst-off countries, and worst-off communities within countries, is not only possible but can be 45 
expected to have profound health benefits. Further improvements in health can also contribute to 46 
economic growth, healthier children can learn more effectively, and reproductive heatlh services can 47 
empower women, creating the potential for futher health gains to expand SDI improvement.  48 
2. The Millennium Development Goal health agenda has been working 49 
Starting around 2000, the global health community, including donors, focused on reducing mortality of 50 
children and mothers, as well as burden from three target conditions--tuberculosis, HIV, and malaria.8–10 51 
Development Assistance for Health (DAH) increased profoundly until 2010 but has since stagnated.11 52 
The share of DAH allocated to the Millennium Development Goal (MDG) agenda has remained constant 53 
even with the expanded SDG health agenda in place since 2015. This concerted focus on communicable, 54 
maternal, neonatal, and nutritional disorders (CMNN) has led to faster progress in combatting these 55 
diseases compared to non-communicable diseases (NCDs) and injuries (figure 2). Reductions in age-56 
standardised disability-adjusted life-year (DALY) rates since 1990 have been largest for the CMMN 57 
causes and progress has been fastest in the most recent decade, even taking into account the stagnation 58 
in DAH since 2010. Despite population growth, particularly in the lowest SDI countries, the absolute 59 
number of DALYs from these causes has also declined. In contrast, age-standardised NCD DALY rates 60 
have barely declined; population growth and ageing have in fact resulted in a steady increase in the 61 
number of DALYs lost due to these causes. Age-standardised injury DALY rates have declined but at rates 62 
well below those of CMNN causes. 63 
 64 
3. Health systems need to be more agile to adapt to the rapid shift to 65 
NCDs and disabilities 66 
Countries in the low-middle and middle SDI quintiles have undergone rapid transitions from burden 67 
dominated by CMNN causes to NCDs and injuries. The low-middle quintile increased from 37.8% of total 68 
DALYs caused by NCDs and injuries in 1990 to 66.0% in 2019, with a similar pattern in the middle quintile 69 
as well. The GBD assessment of universal health coverage (UHC) effective coverage allows 70 
disaggregation of coverage into CMNN interventions and NCD interventions, as shown in figure 3. While 71 
CMNN coverage rises almost linearly with higher SDI, NCD intervention coverage lags behind. Countries 72 
undergoing rapid transitions have burden profiles dominated by NCDs but health systems that are 73 
struggling to deliver effective interventions for NCDs. As countries’ health profiles shift to NCDs, there is 74 
a middle-SDI quintile gap that emerges, where the most important interventions for improving health in 75 
that context have low coverage. Despite this gap, most policy discussion, including WHO engagement 76 
with countries, remains firmly focused on the CMNN agenda, ignoring the epidemiological 77 
heterogeneity of low and middle SDI countries. The legacy focus on CMNN causes, and a failure to more 78 
purposefully anticipate the inevitable shift to NCDs, is evident even in UHC discussions; the official UN 79 
UHC service indicator (3.8.1) does not include the coverage of any intervention targeting NCDs.12  80 
A second challenge is emerging at higher levels of development, where the majority of DALYs in high SDI 81 
countries now arises not from premature mortality, but from loss of functional health. This shift is driven 82 
by a combination of ageing populations and stagnant age-specific rates for the main sources of 83 
functional health loss including musculoskeletal disorders, mental disorders, substance abuse, vision 84 
loss, and hearing loss. The fraction of global DALYs due to years lived with disability (YLDs) increased 85 
from 20.7% in 1990 to 33.9% in 2019. Over the same period, the number of countries where YLDs 86 
exceeded years of life lost (YLLs) increased from one to 29 This shift is mirrored in health expenditures in 87 
these high SDI nations. Musculoskeletal disorders were the largest health expenditure in the US in 2016 88 
at $380 billion,13 larger than either cardiovascular diseases or cancers. Health systems appear to be ill-89 
prepared for this shift. Most policy discussion remains focused on cardiovascular diseases and 90 
cancers.14–16 The innovation pipeline for the main disabling conditions (musculoskeletal, mental, and 91 
neurological disorders) remains poor.17–19 Comparatively low investment in research on underlying 92 
causes and in therapeutic innovations for key causes of functional health loss is exacerbating this 93 
widespread and unacceptable neglect: for example, the US National Institutes of Health budget on 94 
cardiovascular diseases and cancers is dramatically larger than on musculoskeletal disorders ($8.60 95 
billion combined vs $734 million in 2018).20  96 
4. Public health is failing to stem the increase in critical global risk factors 97 
The potential to improve health through risk reduction is well documented in GBD 2019. All risks 98 
quantified in GBD collectively account for 48% of global DALYs. Of these risks, exposure to a number of 99 
risks highly correlated with SDI have been steadily decreasing as global SDI increases: household air 100 
pollution; child growth failure; and unsafe water, sanitation, and handwashing. In addition, there have 101 
been notable declines in exposure to smoking. Figure 4 shows the annualised rate of change in exposure 102 
from 2010 to 2019 for select risk factors ordered by global attributable. Among the 15 leading causes of 103 
attributable DALYs shown, high systolic blood pressure (SBP), high body-mass index (BMI), high fasting 104 
plasma glucose (FPG), ambient particulate matter pollution, alcohol use, and durg use stand out because 105 
of the rates above 0.5% per year in exposure.  106 
If public health action and public policy could stop or reverse the trends up in exposure to these risks 107 
and the benefits would be huge. What lessons can we learn from our collective failure to leverage 108 
knowledge on the harms associated with these risks to improve health? Simply providing information on 109 
the harms does not appear to be sufficient. The one major adult behavioural risk for which a cocktail of 110 
interventions, built around strong government policy commitment has had at least partial success is 111 
tobacco smoking—down 1.2% per year globally since 2010— suggesting important lessons for strategies 112 
to reduce obesity, for example. This progress is likely linked more to taxation and legislation facilitated 113 
in part by the Framework Convention on Tobacco Control;21 and much less to providing information to 114 
consumers, particularly in lower SDI countries, about the harms of tobacco.22,23 The failure to slow or 115 
reverse the global rise in body-mass index, to facilitate healthier diets, or to increase levels of physical 116 
activity is likely due in part to inadequate policy attention and funding for public health action and 117 
behavioural research. The steady rise of these risks is likely to pose a massive threat to future health 118 
progress everywhere.24,25 The rise of key metabolic risks and the slowing or reversals of the long-term 119 
declines in cardiovascular diseases seen in some locations suggest that we may be approaching a 120 
watershed in terms of life expectancy gains.26 Governments must invest more in research and action to 121 
tackle these stagnating or worsening risk exposures. A core obstacle to accelerating progress on 122 
behavioural risks is the notion of individual agency and the need for governments to let individuals make 123 
their own choices. This is naïve; individual choices are influenced by context, education, and availability 124 
of alternatives. Governments can and should take action to facilitate healthier choices by rich and poor 125 
individuals alike. And where there is a major risk to population health, more concerted government 126 
action through regulation, taxation, and subsidies, drawing lessons from decades of tobacco control, 127 
may be required to protect the public’s health.  128 
5.Social, fiscal, and geopolitical challenges of inverted population 129 
pyramids 130 
As an extension of GBD, Vollset and colleagues6 have developed population scenarios for each country 131 
and territory to 2100. In 2019, 34 countries had negative natural rates of increase; in other words, the 132 
crude death rate was greater than the crude birth rate. When the natural rate of increase is negative in 133 
the absence of net in-migration, populations will decline. Two variables, female educational attainment 134 
and met contraceptive need, explain 80.5% of the variation in the completed fertility for a cohort of 135 
women. When met contraceptive need reaches 95% and average educational attainment reaches 16 136 
years, the total fertility rate, on average, will decline to 1.4. Globally, educational attainment is rising, as 137 
is contraceptive met need.27,28 The effect of these trends will be to rapidly increase the number of 138 
countries with a negative natural rate of increase (figure 5).6 Negative rates of natural increase lead 139 
progressively over time to inverted population pyramids, where older 5-year age groups have more 140 
individuals in them than younger 5-year age groups. In 2050, China will have 79.6 million 70–74 year 141 
olds but only 46.0 million 0–4 year olds. Negative natural rates of increase will lead inexorably to an 142 
intensified national debate on immigration. The profound social, fiscal, economic, and geopolitical 143 
challenges of an inverted age pyramid can be addressed through liberal immigration policies. Countries 144 
such as Canada, Australia, New Zealand, and the US have already used such a strategy to maintain or 145 
increase the working age population. Some countries will try to increase fertility rates rather than accept 146 
migrants into their societies. Russia has identified raising the birth rate as their number one health 147 
priority.29 In such cases, it is imperative that any policy initiatives protect women’s sexual and 148 
reproductive rights. Yet, attempts to increase fertility rates through economic incentives and paid 149 
maternal and paternal leave in countries like Sweden,30 Singapore,31 South Korea,32 Japan,33 and Taiwan 150 
(Province of China)34 have had a minimal effect on fertility rates.6 151 
Conclusion 152 
Success in reducing burden from CMNN causes through global collective action to fund key programmes 153 
should be celebrated. Catch-up social and economic development is fuelling more rapid health progress 154 
in the lower SDI quintiles. But there is reason to believe that while the last 70 years have largely been a 155 
story of sustained improvements in health, rising critical risks including high BMI, high FPG, and ambient 156 
air pollution and stagnantation for many other behavioural risks including diet quality and physical 157 
activity may well attenuate progress. Most alarmingly, the half century of mortality declines in 158 
cardiovascular diseases have slowed significantly, or reversed, in some high SDI nations. New challenges 159 
such as rising temperature and the associated increases in poverty need to be urgently addressed. Low 160 
fertility in many nations will likely emerge as a profound social and economic issue. Tracking progress 161 
across this myriad of global health challenges, and with health development goals more broadly, 162 
reinforces the policy value of global comparative assessments in the health sector such as the ongoing 163 
Global Burden of Disease Study.  164 
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Figures 255 
Figure 1. Change in healthy life expectancy (HALE) from 2000 to 2019 disaggregated by Socio-256 
demographic Index quintiles as assessed in 2019. Expected change in HALE related to change in SDI is 257 
based on fitting spline functions to the relationship between age-specific mortality and SDI and age-258 
specific years lived with disability per capita and SDI.  259 
Figure 2. Global annualised rates of change for age-standardised DALY rates and DALY counts for two 260 
periods, 1990–2010 and 2010–2019. Results are shown for three broad cause groups: communicable, 261 
maternal, neonatal, and nutritional disorders (CMNN); non-communicable diseases (NCDs); and injuries.  262 
Figure 3. Relationships of UHC effective coverage in 204 countries and territories in 2019 for 263 
interventions targeting communicable, maternal, neonatal, and nutritional diseases (CMMN) and non-264 
communicable diseases (NCDs) versus Socio-demographic Index (SDI). 265 
Figure 4. Global annualised rates of change 2010–2019 in exposure measured using the Summary 266 
exposure value (SEV) for select risks. Risk factors are ordered by global attributable DALYs. Summary 267 
exposure value is an integrated measure of risk exposure that allows comparison across continuous, 268 
polytomous, and dichotomous risk factors.  269 
Figure 5. Number of countries and territories with negative natural rate of population increase observed 270 
1950–2019 and in the reference forecast scenario for 2020–2100. The nature rate of increase is negative 271 
when the crude death rate exceeds the crude birth rate.  272 
